XVIII. Management of nodular lymphocyte predominant Hodgkin lymphoma.
about
SEOM clinical guidelines for the treatment of Hodgkin's lymphoma.Advanced stage nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents: clinical characteristics and treatment outcome - a report from the SFCE & CCLG groups.Rituximab plus ABVD in newly diagnosed nodular lymphocyte-predominant Hodgkin lymphoma.
P2860
XVIII. Management of nodular lymphocyte predominant Hodgkin lymphoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
XVIII. Management of nodular lymphocyte predominant Hodgkin lymphoma.
@en
type
label
XVIII. Management of nodular lymphocyte predominant Hodgkin lymphoma.
@en
prefLabel
XVIII. Management of nodular lymphocyte predominant Hodgkin lymphoma.
@en
P2860
P356
P1476
XVIII. Management of nodular lymphocyte predominant Hodgkin lymphoma.
@en
P2093
Ranjana H Advani
Richard T Hoppe
P2860
P356
10.1002/HON.2226
P478
33 Suppl 1
P577
2015-06-01T00:00:00Z